Medical Wearables For Improved Outcomes in Diabetes (Wearable USA 2019)

Dr Rohan Sonawane, Clinical Marketing Manager
Medtronic Diabetes
United States
 

Downloads

USA 2019 _ Medtronic PLC _ Presentation*
USA 2019 _ Medtronic PLC _ Presentation*
USA 2019 _ Medtronic PLC _ Presentation*

If you already have access, please [Login]
Access can be purchased via IDTechEx Credits
IDTechEx

Presentation Summary

Approximately 415 million people around the world have diabetes and an estimated 50% of these patients are not in control of their disease. Annual spending on diabetes-related healthcare is $673 billion dollars. Continuous Glucose Monitoring (CGM) has helped people with Type 1 and Type 2 diabetes to manage their disease more effectively. CGM technology makes it easier for T1 and T2 patients, their HCPs and caregivers to gain deeper insights into daily glucose fluctuations, thereby increasing quality of life and reducing complications. We have seen tremendous improvements in sensor performance, duration and integration capabilities with insulin pump over the last few years. This presentation will talk about current solutions in the diabetes healthcare market and future trends. An overview of glucose sensor technology will also be covered, how it works as a standalone device, as well as with insulin pumps. We will also discuss recent advances in the CGM field and collaborations of medical device companies with IT to further enhance patient outcomes.

Speaker Biography (Rohan Sonawane)

Rohan Sonawane is currently the Clinical Marketing Manager at Medtronic, in the diabetes healthcare segment. He is a physician and MBA by background and has over 10 years of experience in the healthcare industry, across various domains such as medical education, medico-marketing, strategy, product launches and global marketing. He is currently leading the US projects and supporting OUS teams in effective integration of Medtronic's CGM and insulin pump devices in the clinical trials for better, faster and more economical outcomes. He has also worked with big pharma, CRO, genetics and bariatric groups to offer them effective solutions for their clinical trials.

Company Profile (Medtronic PLC)

About Medtronic Diabetes:
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
 
About Medtronic:
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
View Medtronic PLC Timeline